Prostate Cancer: Progress & Promise
A series of lectures featuring an interactive Expert Roundtable moderated by Bruce A. Chabner, MD

This is a time of rapid change in the field of prostate cancer therapeutics. These lectures and expert roundtable in the first series summarized the status of key new treatment modalities and their likely place in the management of this disease, outlined the next steps in their use in combination and in the adjuvant setting, and discussed ways they may lead to personalized therapies based upon biomarkers and genetic testing.

The first series was held April 30, 2011 at Massachusetts General Hospital. The second series was held in conjunction with the 2011 Annual Meeting in Belfast, Northern Ireland. The third series will be held at the STO Annual Meeting in 2012. More information is forthcoming.

These educational activities are supported by educational grants from: 

 

Brought to you in partnership with